Controlled Decompression Alleviates Brain Injury via Attenuating Oxidative Damage and Neuroinflammation in Acute Intracranial Hypertension
Related Experiment Video
Updated: Jul 31, 2026

A Preclinical Controlled Cortical Impact Model for Traumatic Hemorrhage Contusion and Neuroinflammation
Published on: June 10, 2020
Chonghui Zhang1, Xiao Qian1, Jie Zheng1
1Department of Neurosurgery, The 904th Hospital of PLA, Medical School of Anhui Medical University, Wuxi, Jiangsu 214044, China.
Insights
Controlled decompression (CDC) offers better neuroprotection than rapid decompression (RDC) for acute intracranial hypertension. CDC reduces brain damage by lowering oxidative stress, inflammation, and specific protein levels (UCH-L1 and GFAP).
Area of Science:
- Neurosurgery
- Neuroscience
- Biomedical Engineering
Background:
- Clinical studies confirm controlled decompression (CDC) benefits acute intracranial hypertension (AICH) patients, mitigating complications from rapid decompression (RDC).
- This study investigates the therapeutic potential of CDC using ubiquitin C-terminal hydrolase-L1 (UCH-L1) and glial fibrillary acidic protein (GFAP) in an AICH rabbit model.
Purpose of the Study:
- To evaluate the neuroprotective efficacy of CDC compared to RDC.
- To elucidate the molecular mechanisms underlying CDC's therapeutic effects in AICH, focusing on UCH-L1 and GFAP.
Main Methods:
- Male New Zealand white rabbits were divided into sham-operated, CDC, and RDC groups.
- Plasma and brain tissue were analyzed for UCH-L1, GFAP, oxidative stress markers, and inflammatory cytokines using ELISA and Western blot.
- Neurological scores, brain water content, and protein expression via qPCR and immunofluorescence were assessed.
Main Results:
- CDC significantly improved neurological function and reduced brain water content compared to RDC.
- CDC attenuated neuronal degeneration, oxidative damage, and inflammatory responses more effectively than RDC.
- Plasma UCH-L1 and GFAP levels were significantly lower in the CDC group post-operation.
Conclusions:
- Controlled decompression (CDC) demonstrates superior neuroprotective effects compared to rapid decompression (RDC) in an acute intracranial hypertension model.
- CDC attenuates oxidative damage and inflammatory responses.
- CDC downregulates UCH-L1 and GFAP levels, contributing to its neuroprotective benefits.
Background:
The benefits of controlled decompression (CDC) for patients with acute intracranial hypertension especially in terms of alleviating the complications caused by rapid decompression (RDC) have been confirmed by clinical studies. This study is aimed at evaluating the therapeutic potency of CDC with ubiquitin C-terminal hydrolase-L1 (UCH-L1) and glial fibrillary acidic protein (GFAP) by investigating the potential molecular mechanism in the acute intracranial hypertension (AICH) rabbit model.
Methods:
Male New Zealand white rabbits were randomly subdivided into the sham-operated (SH) group, CDC group, and RDC group. Blood plasma samples and brain tissue were collected 2 days before operation (baseline) and at 3, 6, 24, and 72 hours after operation to measure the levels of UCH-L1, GFAP, oxidative stress indicators, and inflammatory cytokines by performing ELISA or Western blot. The neurological score of the rabbits and brain water content was graded 24 h after surgery. qPCR, immunofluorescence, and FJ-C staining were conducted.
Results:
CDC improved neurological function, lowered brain water content, ameliorated neuronal degeneration, attenuated oxidative damage, and inflammatory responses to a greater extent than RDC. Plasma UCH-L1 level was significantly lower in the CDC group at 3 h postoperatively than in the RDC group. CDC reduced plasma GFAP levels to various degrees at 3 h, 6 h, and 24 h postoperatively compared with RDC. Immunofluorescence confirmed that the expression of UCH-L1 and GFAP in the cortex of the CDC group was lower than that of the RDC group.
Conclusions:
Our data collectively demonstrate that CDC could attenuate oxidative damage and inflammatory responses, downregulate UCH-L1 and GFAP levels, and contribute to an improved neuroprotective effect compared with RDC.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology
Increased Intracranial Pressure l: Introduction
Increased Intracranial Pressure ll: Pathophysiology
Cerebral Edema ll: Pathophysiology
Cytotoxic Edema: Pathophysiology

